Curcumin suppresses cisplatin resistance development partly via modulating extracellular vesicle-mediated transfer of MEG3 and miR-214 in ovarian cancer
Authors:
- 8 February 2017
- journal article
- research article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 79 (3) , 479-487
Abstract
To investigate how curcumin alters the extracellular vesicles’ (EVs) capability to ship drug resistance in ovarian cancer.Keywords
This publication has 24 references indexed in Scilit:
- Polyethylene glycol-phosphatidylethanolamine (PEG-PE)/vitamin E micelles for co-delivery of paclitaxel and curcumin to overcome multi-drug resistance in ovarian cancerInternational Journal of Pharmaceutics, 2014
- Cancer statistics, 2014CA: A Cancer Journal for Clinicians, 2014
- Isolation of Extracellular Nanovesicle MicroRNA from Liver Cancer Cells in Culture2013
- Resistance to platinum-based chemotherapy is associated with epithelial to mesenchymal transition in epithelial ovarian cancerEuropean Journal of Cancer, 2013
- MicroRNA MiR-214 Regulates Ovarian Cancer Cell Stemness by Targeting p53/NanogJournal of Biological Chemistry, 2012
- MEG3 noncoding RNA: a tumor suppressorJournal of Molecular Endocrinology, 2012
- Cell-Secreted Vesicles in Equine Ovarian Follicular Fluid Contain miRNAs and Proteins: A Possible New Form of Cell Communication Within the Ovarian Follicle1Biology of Reproduction, 2012
- Major clinical research advances in gynecologic cancer in 2010Journal of Gynecologic Oncology, 2010
- MicroRNA Expression Profiling in Human Ovarian Cancer: miR-214 Induces Cell Survival and Cisplatin Resistance by Targeting PTENCancer Research, 2008
- Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cellsMolecular Cancer Therapeutics, 2005